Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002375661 | SCV002624456 | pathogenic | Cystic fibrosis | 2024-06-03 | criteria provided, single submitter | clinical testing | The c.40_44delAAACT pathogenic mutation, located in coding exon 1 of the CFTR gene, results from a deletion of 5 nucleotides at nucleotide positions 40 to 44, causing a translational frameshift with a predicted alternate stop codon (p.K14Ffs*29). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV004572268 | SCV005057435 | likely pathogenic | Bronchiectasis with or without elevated sweat chloride 1 | 2024-02-13 | criteria provided, single submitter | clinical testing |